tetano
Editor, Senior Moderator
Ann Clin Microbiol Antimicrob
. 2024 Jun 17;23(1):55.
doi: 10.1186/s12941-024-00715-1. Severe necrotizing tracheobronchitis caused by influenza B and methicillin-resistant Staphylococcus aureus co-infection in an immunocompetent patient
Shu Wang[SUP] #[/SUP][SUP] 1 [/SUP], Jianhua Yang[SUP] #[/SUP][SUP] 1 [/SUP], Wenwu Sun[SUP] #[/SUP][SUP] 2 [/SUP], Yang Tao[SUP] #[/SUP][SUP] 3 [/SUP]
Affiliations
Purpose and method: Necrotizing tracheobronchitis is a rare clinical entity presented as a necrotic inflammation involving the mainstem trachea and distal bronchi. We reported a case of severe necrotizing tracheobronchitis caused by influenza B and methicillin-resistant Staphylococcus aureus (MRSA) co-infection in an immunocompetent patient.
Case presentation: We described a 36-year-old man with initial symptoms of cough, rigors, muscle soreness and fever. His status rapidly deteriorated two days later and he was intubated. Bronchoscopy demonstrated severe necrotizing tracheobronchitis, and CT imaging demonstrated multiple patchy and cavitation formation in both lungs. Next-generation sequencing (NGS) and bronchoalveolar lavage fluid (BALF) culture supported the co-infection of influenza B and MRSA. We also found T lymphocyte and NK lymphocyte functions were extremely suppressed during illness exacerbation. The patient was treated with antivirals and antibiotics including vancomycin. Subsequent bronchoscopy and CT scans revealed significant improvement of the airway and pulmonary lesions, and the lymphocyte functions were restored. Finally, this patient was discharged successfully.
Conclusion: Necrotizing tracheobronchitis should be suspected in patients with rapid deterioration after influenza B infection. The timely diagnosis of co-infection and accurate antibiotics are important to effective treatment.
Keywords: Staphylococcus aureus; Influenza B; Necrotizing tracheobronchitis; Next-generation sequencing; Vancomycin.
. 2024 Jun 17;23(1):55.
doi: 10.1186/s12941-024-00715-1. Severe necrotizing tracheobronchitis caused by influenza B and methicillin-resistant Staphylococcus aureus co-infection in an immunocompetent patient
Shu Wang[SUP] #[/SUP][SUP] 1 [/SUP], Jianhua Yang[SUP] #[/SUP][SUP] 1 [/SUP], Wenwu Sun[SUP] #[/SUP][SUP] 2 [/SUP], Yang Tao[SUP] #[/SUP][SUP] 3 [/SUP]
Affiliations
- PMID: 38886754
- DOI: 10.1186/s12941-024-00715-1
Purpose and method: Necrotizing tracheobronchitis is a rare clinical entity presented as a necrotic inflammation involving the mainstem trachea and distal bronchi. We reported a case of severe necrotizing tracheobronchitis caused by influenza B and methicillin-resistant Staphylococcus aureus (MRSA) co-infection in an immunocompetent patient.
Case presentation: We described a 36-year-old man with initial symptoms of cough, rigors, muscle soreness and fever. His status rapidly deteriorated two days later and he was intubated. Bronchoscopy demonstrated severe necrotizing tracheobronchitis, and CT imaging demonstrated multiple patchy and cavitation formation in both lungs. Next-generation sequencing (NGS) and bronchoalveolar lavage fluid (BALF) culture supported the co-infection of influenza B and MRSA. We also found T lymphocyte and NK lymphocyte functions were extremely suppressed during illness exacerbation. The patient was treated with antivirals and antibiotics including vancomycin. Subsequent bronchoscopy and CT scans revealed significant improvement of the airway and pulmonary lesions, and the lymphocyte functions were restored. Finally, this patient was discharged successfully.
Conclusion: Necrotizing tracheobronchitis should be suspected in patients with rapid deterioration after influenza B infection. The timely diagnosis of co-infection and accurate antibiotics are important to effective treatment.
Keywords: Staphylococcus aureus; Influenza B; Necrotizing tracheobronchitis; Next-generation sequencing; Vancomycin.